Medical Research
(H31J)
990 on File
MARY OBOLENSKY UNDERWOOD LEUKAEMIA FOUNDATION INC
Financial strength (30%)
49/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$97K
Total Revenue
$103K
Total Expenses
$206K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
95.5%
Fundraising Efficiency
71.2%
Operating Reserve
23.96x
Liability-to-Asset
N/A
Revenue Diversification
57.6%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
95.5% | 84.6% |
P10P90
|
Above median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
71.2% | 10.1% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
24.0 mo | 11.7 mo |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
57.6% | 92.2% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-17.0% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
51.4% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-6.4% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $97K | $103K | $206K | 95.5% | — |
| 2024 | $117K | $68K | $212K | 91.2% | — |
| 2023 | $105K | $72K | $163K | 97.4% | — |
| 2022 | $121K | $64K | $131K | 94.6% | — |
| 2021 | $59K | $32K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.